Nasenspray-Ratiopharm® Kinder (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasenspray-Ratiopharm® Kinder, is an imidazoline nasal decongestant presented as a nasal spray for intranasal use. It provides relief of nasal congestion caused by the common cold, sinusitis, and allergic rhinitis in children. GNH USA supplies Nasenspray-Ratiopharm® Kinder as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride acts locally on the nasal mucosa to reduce swelling and improve airflow in several common upper‑respiratory conditions.

Common cold: alleviates congestion and nasal blockage associated with viral upper‑respiratory infection. Sinusitis: reduces mucosal edema, helping to relieve sinus pressure and drainage difficulty. Allergic rhinitis: diminishes nasal swelling caused by allergen‑induced inflammation.

Xylometazoline Hydrochloride may cause local or systemic reactions, most of which are mild and transient.

Common Side Effects: - Burning or stinging sensation in the nose - Mild nasal dryness - Sneezing shortly after application - Transient headache - Taste disturbance (metallic or bitter) - Mild epistaxis (nosebleed)

Serious or Rare Side Effects: - Persistent nasal irritation or ulceration - Severe hypertension (especially with excessive use) - Cardiac arrhythmias in susceptible individuals - Allergic reactions such as rash, itching, or swelling - Rebound congestion after prolonged use (>3‑5 days) - Vision changes or ocular pressure increase (rare).

Before using Nasenspray-Ratiopharm® Kinder, consider the following safety measures.

Age restriction: not recommended for children under 2 years of age. Duration limit: avoid use for more than 3‑5 consecutive days to prevent rebound congestion. Cardiovascular conditions: use with caution in patients with hypertension or heart disease. Drug interactions: consult a healthcare professional if using monoamine oxidase inhibitors or other sympathomimetic agents. Pregnancy and lactation: discuss use with a physician as safety data are limited. Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medicines that affect the sympathetic nervous system.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: additive vasoconstrictive effect. - Other nasal decongestants: increased risk of severe hypertension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt cardiovascular response. - Antihypertensive agents: possible reduction in blood pressure control. - Herbal sympathomimetics (e.g., ephedra): may enhance vasoconstriction. - Caffeine‑containing products: may increase stimulant effects.